Ganadores: Ciencias de la mandioca (NASDAQ: SAVA ) + 23% . Genética del cáncer (NASDAQ: CGIX ) + 23% . Epizyme (NASDAQ: EPZM ) + 15% . Lexicon Pharmaceuticals (NASDAQ: LXRX ) + 15% . Clovis Oncología (NASDAQ: CLVS ) + 13% .
Perdedores: Correvio Pharma (NASDAQ: CORV ) -33% . Capricor Therapeutics (NASDAQ: CAPR ) -17% . Curis (NASDAQ: CRIS ) -16% . Axcella Health (NASDAQ: AXLA ) -16% . IMAC (NASDAQ: IMAC ) -13%
